Transport
Marian Health Center-Smhc
Marian Health Center-Smhc was paid $15.53M by Medicaid between Jan 2018 and Dec 2024, across 126 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoMARIAN HEALTH CENTER-SMHC
SIOUX CITY, IA 51101
SIOUX CITY, IA 51101
33aNPI1538199617assigned 07/04/2006
33bProvider typeAir Ambulance
28Total paid$15.53M
24GClaims304,274
24DCodes billed126
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Air Ambulance providers in Iowa
Rank by total paid#2 of 5
Median peer was paid$32K
This provider vs. median490×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HANSON, JESICA controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,883 | $2.19M | |
| 2019 | 36,153 | $2.08M | |
| 2020 | 37,764 | $1.59M | |
| 2021 | 47,944 | $2.50M | |
| 2022 | 56,441 | $2.71M | |
| 2023 | 55,588 | $2.72M | |
| 2024incomplete | 34,501 | $1.73M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 22,141 | 19,887 | $3.24M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 13,970 | 12,370 | $2.97M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 5,100 | 4,291 | $2.47M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.9% | 8,323 | 7,281 | $1.08M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.9% | 12,982 | 10,358 | $919K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 8,949 | 8,175 | $801K |
| 99001 | 4.4% | 17,193 | 13,403 | $690K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.5% | 2,067 | 1,756 | $382K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 1,908 | 1,634 | $334K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.1% | 740 | 674 | $322K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 6,229 | 5,219 | $268K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 2,254 | 1,994 | $260K |
114 more codes
| 97597 | 1.6% | 2,864 | $244K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.5% | 1,412 | $240K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 1,975 | $199K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 1,350 | $197K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 2,763 | $177K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,975 | $150K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,583 | $98K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,608 | $88K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 544 | $85K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 431 | $56K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 968 | $36K |
| 80050 | General health panel | <1% | 452 | $33K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,902 | $22K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,541 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,540 | $17K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,119 | $15K |
| 80053 | Comprehensive metabolic panel | <1% | 17,687 | $14K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 508 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25,358 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,464 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 29 | $8K |
| 87631 | <1% | 687 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 828 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 1,425 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,790 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,753 | $4K |
| 87400 | <1% | 1,438 | $4K | |
| 80061 | Lipid panel | <1% | 473 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,966 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 30 | $3K |
| 81001 | <1% | 8,469 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 45 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,108 | $2K |
| 84439 | <1% | 1,474 | $2K | |
| 87252 | <1% | 636 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,478 | $2K |
| 86900 | <1% | 285 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 343 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,716 | $1K |
| 83735 | <1% | 2,958 | $995.83 | |
| 85027 | <1% | 3,974 | $982.64 | |
| J2704 | Injection, propofol, 10 mg | <1% | 918 | $966.44 |
| 0002A | <1% | 30 | $958.36 | |
| 81003 | <1% | 3,166 | $849.75 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $814.68 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 493 | $809.89 |
| 87300 | <1% | 636 | $782.95 | |
| 82570 | <1% | 3,895 | $591.35 | |
| G0008 | Administration of influenza virus vaccine | <1% | 29 | $584.72 |
| 83880 | <1% | 2,031 | $571.58 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,674 | $541.00 |
| 87420 | <1% | 181 | $520.99 | |
| 0001A | <1% | 32 | $493.98 | |
| 87077 | <1% | 1,674 | $486.33 | |
| 84484 | <1% | 8,111 | $472.42 | |
| 86140 | <1% | 960 | $461.16 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 358 | $431.92 |
| 83690 | <1% | 3,707 | $390.19 | |
| 82565 | <1% | 87 | $377.33 | |
| 85610 | <1% | 2,372 | $354.73 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,528 | $342.36 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 267 | $313.63 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,107 | $301.19 |
| 87186 | <1% | 1,517 | $264.86 | |
| 84100 | <1% | 1,162 | $255.73 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 254 | $249.87 |
| 83605 | <1% | 3,864 | $233.66 | |
| 84702 | <1% | 596 | $211.22 | |
| 88342 | <1% | 613 | $177.55 | |
| 82077 | <1% | 2,397 | $149.43 | |
| 84481 | <1% | 13 | $137.05 | |
| 87070 | <1% | 1,430 | $135.25 | |
| 82550 | <1% | 834 | $121.30 | |
| 84703 | <1% | 2,407 | $116.57 | |
| 87205 | <1% | 1,546 | $78.30 | |
| 85730 | <1% | 437 | $71.40 | |
| 87088 | <1% | 240 | $62.01 | |
| 85652 | <1% | 275 | $53.50 | |
| 80076 | <1% | 265 | $42.62 | |
| 87075 | <1% | 496 | $33.77 | |
| 82140 | <1% | 14 | $27.96 | |
| 82803 | <1% | 36 | $25.27 | |
| 81025 | <1% | 763 | $25.23 | |
| 80179 | <1% | 998 | $17.71 | |
| 80143 | <1% | 1,070 | $17.71 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 277 | $17.39 |
| 84520 | <1% | 13 | $13.92 | |
| 85380 | <1% | 1,654 | $12.35 | |
| 82553 | <1% | 74 | $11.19 | |
| 81002 | <1% | 364 | $9.93 | |
| 84145 | 0% | 75 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 159 | $0.00 |
| 93017 | 0% | 15 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 95 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 271 | $0.00 |
| 36600 | 0% | 19 | $0.00 | |
| 74018 | 0% | 17 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 143 | $0.00 |
| 86850 | 0% | 103 | $0.00 | |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 261 | $0.00 |
| 80320 | 0% | 80 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 258 | $0.00 |
| 86901 | 0% | 285 | $0.00 | |
| 80329 | 0% | 26 | $0.00 | |
| 87184 | 0% | 41 | $0.00 | |
| 87040 | 0% | 374 | $0.00 | |
| 80047 | 0% | 17 | $0.00 | |
| 94760 | 0% | 36 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 40 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 107 | $0.00 |
| 96376 | 0% | 118 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 16 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 14 | $0.00 |
| 82330 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANSON, JESICA (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Medical Services | Sioux City, IA | $2.00M |
| Mercy Medical Services | South Sioux City, NE | $1.06M |
| Mercy Medical Services | Correctionville, IA | $625K |
| Mercy Medical Services | Kingsley, IA | $573K |
| Marian Health Center-Smhc | Sioux City, IA | $431K |
| Dunes Medical Laboratories | Dakota Dunes, SD | $417K |
| Mercy Medical Services | Sioux City, IA | $298K |
| Mercy Medical Services | Dakota Dunes, SD | $168K |
| Mercy Medical Services | Moville, IA | $79K |
| Mercy Medical Services | Dakota Dunes, SD | $13K |
| Mercy Medical Services | Sioux City, IA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.